Variant report
Variant | esv3517042 |
---|---|
Chromosome Location | chr8:1509145-1512243 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs533360808 | chr8:1509146-1509147 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs143588208 | chr8:1509165-1509166 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs145966326 | chr8:1509173-1509174 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs535687530 | chr8:1509195-1509196 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs555901098 | chr8:1509218-1509219 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs191139899 | chr8:1509228-1509229 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs538111643 | chr8:1509241-1509242 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs536158929 | chr8:1509260-1509261 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs558023476 | chr8:1509279-1509280 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs530316346 | chr8:1509306-1509307 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs577268771 | chr8:1509311-1509312 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs540205201 | chr8:1509341-1509342 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs73546213 | chr8:1509359-1509360 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs573649794 | chr8:1509360-1509361 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs542458152 | chr8:1509365-1509366 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs138370257 | chr8:1509383-1509384 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs112397408 | chr8:1509403-1509404 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs386720649 | chr8:1509408-1509409 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs67393787 | chr8:1509412-1509413 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs554742406 | chr8:1509419-1509420 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs55811016 | chr8:1509420-1509421 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs371407433 | chr8:1509423-1509424 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs373727306 | chr8:1509435-1509436 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs2906579 | chr8:1509465-1509466 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs2956901 | chr8:1509482-1509483 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs2956902 | chr8:1509496-1509497 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs59096592 | chr8:1509518-1509519 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs549323097 | chr8:1509519-1509520 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs569151268 | chr8:1509532-1509533 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs184062044 | chr8:1509534-1509535 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs75453328 | chr8:1509549-1509550 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs554952222 | chr8:1509567-1509568 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs571572360 | chr8:1509570-1509571 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs533573216 | chr8:1509578-1509579 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs4876092 | chr8:1509586-1509587 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs546950804 | chr8:1509592-1509593 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs568297925 | chr8:1509608-1509609 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs369340806 | chr8:1509635-1509636 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs113368685 | chr8:1509648-1509649 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs144304045 | chr8:1509664-1509665 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs61387730 | chr8:1509682-1509683 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs148711488 | chr8:1509733-1509734 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs113671778 | chr8:1509734-1509735 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs572277640 | chr8:1509747-1509748 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs189418201 | chr8:1509761-1509762 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs560456744 | chr8:1509763-1509764 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs141441245 | chr8:1509783-1509784 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs369003201 | chr8:1509811-1509812 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs549115980 | chr8:1509815-1509816 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs115696204 | chr8:1509836-1509837 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ovarian cancer | 21720365 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Congenital diaphragmatic hernia | 21341218 | CNVD |
Cancer | 18840272 | CNVD |
Pilocytic astrocytoma | 18622384 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 16573809 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
abnormal development | 18461090 | CNVD |
Crohn''s disease | 19220326 | CNVD |
Psoriasis | 19220326 | CNVD |
Prostate cancer | 21965145 | CNVD |
Prostate cancer | 18515986 | CNVD |
Chronic obstructive pulmonary disease | 20378733 | CNVD |
Autism | 18414403 | CNVD |
Cancer | 21183584 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Breast cancer | 17603634 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Cervical cancer | 17311676 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Schizophrenia | 20877625 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Breast cancer | 17001317 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Heart disease | 21282601 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Breast cancer | 17393978 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Breast cancer | 20837533 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 22429812 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21264507 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Prostate cancer | 21088497 | CNVD |
Breast cancer | 20940404 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Gastric cancer | 17167181 | CNVD |
Prostate cancer | 16705090 | CNVD |
8p-syndrome | 17576883 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Prostate cancer | 17245344 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Cancer | 16751803 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 21785460 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 21509527 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Epilepsy | 22083797 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Breast cancer | 21364760 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Autism | 20531469 | CNVD |
Breast cancer | 20932292 | CNVD |
Congenital diaphragmatic hernia | 21064195 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Ependymoma | 20639864 | CNVD |
Ovarian cancer | 22355333 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:1506000-1516000 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
2 | chr8:1507200-1509800 | Enhancers | Fetal Brain Male | brain |
3 | chr8:1507200-1512000 | Weak transcription | Fetal Brain Female | brain |
4 | chr8:1509400-1509800 | Enhancers | Spleen | Spleen |
5 | chr8:1509800-1511000 | Weak transcription | Fetal Brain Male | brain |
6 | chr8:1511000-1514000 | Enhancers | Fetal Brain Male | brain |
7 | chr8:1511400-1512200 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
8 | chr8:1511600-1513000 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
9 | chr8:1511600-1513000 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
10 | chr8:1511600-1513000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
11 | chr8:1512000-1512600 | Enhancers | Fetal Brain Female | brain |